Details

Autor(en) / Beteiligte

• Montes, Daniel
• Hulshizer, Cassondra A
• Myasoedova, Elena
• Davis, John M
• Hanson, Andrew C
• Duarte-Garcia, Ali
• Figueroa-Parra, Gabriel
• Chevet, Baptiste
• Crowson, Cynthia S

Titel

Utilisation of cardiovascular preventive services in a rheumatoid arthritis population-based cohort

Ist Teil von

• Rheumatic & musculoskeletal diseases open, 2023-11, Vol.9 (4), p.e003318

Ort / Verlag

England: EULAR

Erscheinungsjahr

2023

Quelle

MEDLINE

Beschreibungen/Notizen

• ObjectivesThe objective is to examine utilisation of cardiovascular preventive services in patients with rheumatoid arthritis (RA), compared with a non-RA population, and to examine cardiovascular disease (CVD) screening rates among RA patients without diabetes mellitus (DM), hypertension or hyperlipidaemia to non-RA patients with one of these diagnoses.MethodsAll ≥18-year-old patients with an RA diagnosis living in one of eight Minnesota counties on 1 January 2015 were included and matched (1:1) by sex, age and county to non-RA comparators. Rates of screening for CVD risk factors, including DM (ie, glucose), hypertension (ie, blood pressure) and hyperlipidaemia (ie, lipids), were compared between groups using Cox models.ResultsThe study included 1614 patients with RA and 1599 non-RA comparators. DM screening was more common among patients with RA (HR: 1.10, 95% CI: 1.01 to 1.19), as was hypertension screening (HR: 1.37, 95% CI: 1.24 to 1.52). Hyperlipidaemia screening in RA was similar to comparators (HR: 0.99, 95% CI: 0.89 to 1.10). Conversely, patients with RA and no CVD risk factors had a lower probability of undergoing diabetes (HR: 0.67, 95% CI: 0.57 to 0.78) and hyperlipidaemia screening (HR: 0.65, 95% CI: 0.54 to 0.79) than non-RA patients with only one CVD risk factor diagnosis. Hypertension screening was similar between both groups.ConclusionsRA patients undergo CVD preventive screening at rates at least comparable to the general population. However, patients with RA as their sole CVD risk factor were less likely to undergo screenings, despite an equivalent-to-higher risk as the traditional CVD risk factors. These findings demonstrate opportunities for improvement of RA patient care.